Skip to content

A clinical trial to study the effects of panchshirish agad ghan vati and panchshirish agad ghan vati with phalatrikadi kwath ghan vati, in alcoholic fatty liver disease [garavisha janya yakrut vikar] patients .

Comparative Clinical Study On Phaltrikadikwath Ghan Vati with and without Panchshirisha Agad Ghan Vati on Garavisha Janya Yakrut Vikara w.s.r. Alcoholic Fatty Liver Disease. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084778
Enrollment
30
Registered
2025-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K700- Alcoholic fatty liver

Interventions

None listed

Sponsors

National Institute of Ayurveda jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age between 18 to 60 years in either sex Patient having signs, symptoms of Garavisha (Alcohol) Janya Yakrut Vikara with deranged LFT and USG showing changes of fatty liver disease grade-1 & grade-2 Follow up cases of Garavisha janya yakrut vikara w.s.r. to Alcoholic fatty liver Disease

Exclusion criteria

Exclusion criteria: Patients of fatty liver disease with severe complications e.g. Fatty liver disease grade -3, Cirrhosis, Carcinoma, End stage liver disease, Septicaemia, etc. Patients with other serious health issues Known cases of Viral Hepatitis Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Clinical improvement in sign, symptoms of Garavisha janya yakrut vikara.Timepoint: 45 days

Secondary

MeasureTime frame
Improvement in objective parametersTimepoint: 45 days

Countries

India

Contacts

Public ContactAnupam Saini

National Institute of Ayurveda

dramolkaduayu@gmail.com9834366502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026